臨床試驗

CIRSE Registry for LifePearl Microspheres

NCT：NCT03086096 · COMPLETED

NCT IDNCT03086096

狀態COMPLETED

開始日期2018-02-02

完成時間2022-04-30

SponsorCardiovascular and Interventional Radiological Society of Europe (OTHER)

First posted2017-03-22

Last updated2026-05-13

簡要摘要

The application of transarterial chemoembolisation (TACE) using LifePearl Microspheres loaded with Irinotecan in liver-only or liver-dominant metastatic disease in patients with colorectal adenocarcinoma will be observed. The registry has the following objectives: 1. map the exact indications that the device is being used for and at which stage in treatment it is being applied 2. to assess observed treatment outcomes in terms of safety and effectiveness as well as trying to determine any predictive response factors

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。